Molecular Transducers of Physical Activity Consortium

NACompletedINTERVENTIONAL
Enrollment

1,837

Participants

Timeline

Start Date

August 28, 2019

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Physical Activity
Interventions
OTHER

EE Training

Participants randomized to EE engage in four center-based EE sessions each week for 12 weeks; each session lasting roughly 1-hour with a 40-45 minute stimulus phase and the remaining time being used to warm up and cool down. Each week, two of the sessions occur on a cycle ergometer and two involve treadmill exercise (4 total sessions per week). During all sessions, the participant's heart rate is monitored to ensure they maintain exercise intensity at 70% of heart rate reserve (± 5%). Periodically during training sessions perceptual data from participants are recorded, which is used to track the subjective experience of participants and in interpreting adherence data.

OTHER

RE Training

Participants randomized to RE engage in four center-based RE sessions each week for 12 weeks; each session lasting roughly 1-hour with a 40-45 minute stimulus phase and the remaining time being used to warm up and cool down. The prescription is a 2-day split, meaning approximately half of the major muscle groups are exercised each session and each muscle group is exercised twice per week. Two sessions per week include seven exercises that focus on the hips/thighs, back and biceps, and the other two sessions per week include seven exercises that focus on the chest, shoulders, triceps, calves and abdominal muscles. The first set per muscle group is a warm-up performed at 50-70% of prescribed loads that are based on 10-repetition maximum (10RM). Three sets per exercise are then performed at 10RM intensity. Load increases when a participant can perform 12 repetitions for 2 of 3 sets of an exercise. During all sessions, heart rate is monitored and perceived exertion is recorded.

Trial Locations (11)

15260

University of Pittsburgh, Pittsburgh

27710

Duke University Medical Center, Durham

27858

East Carolina University, Greenville

32803

Florida Hospital / Advent Health, Orlando

35294

University of Alabama at Birmingham, Birmingham

47306

Ball State University, Muncie

70808

Pennington Biomedical Research Center, Baton Rouge

77590

University of Texas Medical Branch - Galveston, Galveston

78229

University of Texas Health Science Center, San Antonio, San Antonio

80217

University of Colorado Denver, Denver

90048

Cedars-Sinai Medical Center, Los Angeles

Sponsors
All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

collaborator

Stanford University

OTHER

collaborator

Broad Institute of MIT and Harvard

OTHER

collaborator

Duke University

OTHER

collaborator

Emory University

OTHER

collaborator

Icahn School of Medicine at Mount Sinai

OTHER

collaborator

Pacific Northwest National Laboratory

FED

collaborator

University of Michigan

OTHER

collaborator

Wake Forest University

OTHER

collaborator

University of Vermont

OTHER

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

collaborator

Mayo Clinic

OTHER

lead

Wake Forest University Health Sciences

OTHER

NCT03960827 - Molecular Transducers of Physical Activity Consortium | Biotech Hunter | Biotech Hunter